1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

SingStrong-A singing and breathing retraining intervention for respiratory and other common symptoms of long COVID: A pilot study, 2022, Cahalan et al

Discussion in 'Long Covid research' started by Andy, Apr 2, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    21,940
    Location:
    Hampshire, UK
    Abstract

    Background: Management of Long COVID (LC) is hugely challenging for clinicians. This pilot study evaluated a breathing retraining and singing programme (SingStrong for LC) to address common LC symptoms. The study hypothesized that this intervention would improve symptoms impacting disordered breathing and participant wellbeing.

    Methods: The 10-week, bi-weekly online programme was comprised of a 45-min class of mindfulness, breathing retraining, vocal exercises, and singing. Sessions were recorded for non-attenders and conducted by a trained vocal coach experienced in respiratory cohorts. Persons with a confirmed COVID-19 diagnosis and persisting symptoms were invited to participate. Demographic and COVID-19 data were collected, and the DePaul Symptom Questionnaire Short Form (DSQ- SF) and COVID-19 Yorkshire Rehab Screen questionnaires were administered. Post-intervention focus groups were also conducted.

    Results: Of 27 (F = 23(85%)) participants recruited, data from 21 who completed at least 10 (50%) classes were analysed. Participants showed significant pre-post-intervention improvements in all breathlessness symptoms (at rest: P < 0.001; dressing: P = 0.01; stairs: P < 0.001), fatigue (P = 0.03), usual activities (P = 0.04), pain/disability (P = 0.03), voice quality (P = 0.01), and communication/cognition (P = 0.04). Pre-post number of instances meeting DSQ-SF criteria for myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) decreased by a net of nine cases (14.3%). No association between COVID-19 hospitalisation status and diagnosis of ME/CFS was identified. Qualitative feedback from eight participants was overwhelmingly positive with all reporting improvements in breathing and general well-being.

    Conclusion: The SingStrong programme shows promise as a viable treatment option for LC sufferers. Future studies are required to further investigate the efficacy of this intervention.

    Abstract on PubMed, https://pubmed.ncbi.nlm.nih.gov/35359819/
    Open access, https://www.cjrt.ca/wp-content/uploads/cjrt-2021-074.pdf
     
    oldtimer, Hutan, shak8 and 1 other person like this.
  2. InitialConditions

    InitialConditions Senior Member (Voting Rights)

    Messages:
    1,585
    Location:
    North-West England
    **puts down shopping bags and breaks into song**
     
    Dolphin, oldtimer, Hutan and 10 others like this.
  3. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,884
    Location:
    Aotearoa New Zealand
    no controls, natural recovery
    substantial dropouts, with only 8 of the 27 participants recruited providing qualitative feedback

    Presumably the Singstrong people will be sending notes to the Welsh National Opera people on how to ensure a positive result for an intervention
     

Share This Page